| 000 | 01374 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516223338.0 | ||
| 264 | 0 | _c20150410 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1558-3163 | ||
| 024 | 7 |
_a10.1016/j.rdc.2014.05.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWard, Michael M | |
| 245 | 0 | 0 |
_aRecent clinical trials in lupus nephritis. _h[electronic resource] |
| 260 |
_bRheumatic diseases clinics of North America _cAug 2014 |
||
| 300 |
_a519-35, ix p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Review | ||
| 650 | 0 | 4 |
_aAzathioprine _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEthnopharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLupus Nephritis _xdrug therapy |
| 650 | 0 | 4 | _aMedication Therapy Management |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aOrgans at Risk |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tRheumatic diseases clinics of North America _gvol. 40 _gno. 3 _gp. 519-35, ix |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rdc.2014.05.001 _zAvailable from publisher's website |
| 999 |
_c24016134 _d24016134 |
||